Completed PHASE4 INTERVENTIONAL 2-arm NCT04557943

Prolotherapy Intervention Effect in Patient With Knee Osteoarthritis

The Level of Cartilage Oligomeric Matrix Protein (COMP) and Urinary C-Terminal Telopeptides of Type II Collagen (uCTX-II) After Prolotherapy Intervention and The Functional Outcome in Patient With Knee Osteoarthritis

Sponsor: Hasanuddin University

Conditions Knee Osteoarthritis

Interventions Prolotherapy Sodium Hyaluronate

Updated 5 times since 2020 Last updated: Nov 17, 2020 Started: Sep 1, 2019 Primary completion: Apr 30, 2020 Completion: Aug 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Knee Osteoarthritis, this trial is completed. The trial is conducted by Hasanuddin University and has accumulated 5 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Dec 2020 — Jan 2021 [monthly]

Completed PHASE4
Oct 2020 — Dec 2020 [monthly]

Completed PHASE4

First recorded

Sep 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hasanuddin University

Data source: Hasanuddin University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Makassar, Indonesia